Jan Krzewiński

President, Polpharma Biologics Gdańsk

Jan Krzewiński is the President of Polpharma Biologics. Prior to his current position Jan held various roles at Polpharma including Director of the Chairman’s Strategic Projects Office. Before joining Polpharma Jan worked at Mid Europa Partners, the largest CEE-focused private equity fund where he was responsible for overseeing and executing investments. While at Mid Eurpoa Jan held supervisory board positions at among others: the Lux Med Group, Diagnostyka, Alpha Medical and Polskie Koleje Linowe. Outside of his business activities Jan serves on the board of the EFC Educational Foundation. Jan is a graduate of the London School of Economic and Political Science (BSc) and John Hopkins University, SAIS (MA).

All speakers

Jürg Burri

Ambassador of Switzerland

Michał Stępień

President of the Polish - Swiss Chamber of Commerce; Country Head UBS Poland

Piotr Arak

Director of the Polish Economic Institute

Liliane Brunner Halbach

Expert in Global Pharma and Life Science

Piotr Dardziński

President of Łukasiewicz Research Network

Bart Dzikowski

Managing Director, Head of Transactions & Legal of Novartis Venture Fund

Neil Goldsmith

Director Strategy, BaseLaunch

Jacek Jemielity

President at ExploRNA Therapeutics

Jordi Montserrat

Co-Founder and Managing Partner in Venturelab

Radosław Sierpiński

Acting President of the Medical Research Agency

Michał Walczak

Co-founder and a Chief Scientific Officer at Captor Therapeutics

Irma Veberič

General Manager Roche Poland

Michał Wszoła

Transplantation surgeon, founder and CEO of Polbionica

Agnieszka Sznyk

President of the Board INNOWO

Pablo Padrutt

Head of Economic, Financial and Scientific Affairs at the Embassy of Switzerland in Poland

Ulrich Schwendimann

Managing Director of the Polish-Swiss Chamber of Commerce